Oskar Adolfsson

USPTO Granted Patents = 17 (Patent Applications = 2)

CIPO Patents = 5 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 53(Granted Patents)

Location History:

Lausanne, CH (2022)
Bercher, CH (2015 - 2023)

Company Filing History:

Katholieke Universiteit Leuven

patents

where one patent can have more than one assignee

Years Active: 2015-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11555065 - Anti-Tau antibodies and methods of use (2023-01-17),

2. 11466077 - Misfolded TDP-43 binding molecules (2022-10-11),

3. 11427629 - Anti-Tau antibodies and methods of use (2022-08-30),

4. 11352419 - Anti-tau antibodies and methods of use (2022-06-07),

5. 10836817 - Anti-Tau antibodies and methods of use (2020-11-17),

6. 10711058 - Anti-Tau antibodies and methods of use (2020-07-14),

7. 10633436 - Anti-tau antibodies and methods of use (2020-04-28),

8. 10336819 - Anti-Tau antibodies and methods of use (2019-07-02),

9. 10329344 - Anti-Tau Antibodies and methods of use (2019-06-25),

10. 10112990 - Anti-Tau antibodies and methods of use (2018-10-30),

11. 10100104 - Methods of diagnosing tau-protein-associated disease (2018-10-16),

12. 10066010 - Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau (2018-09-04),

13. 9657091 - Humanized tau antibody (2017-05-23),

14. 9598485 - Anti-tau antibodies and methods of use (2017-03-21),

15. 9540434 - Phosphospecific antibodies recognising tau (2017-01-10),

Title: Oskar Adolfsson: Innovator in Antibody Research

Introduction

Oskar Adolfsson is a prominent inventor based in Bercher, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for various neurological disorders. With a total of 17 patents, his work has the potential to impact the diagnosis and treatment of several debilitating conditions.

Latest Patents

Among his latest patents are groundbreaking inventions such as "Anti-Tau antibodies and methods of use." This invention provides anti-Tau antibodies and outlines methods for their application. Another notable patent is "Misfolded TDP-43 binding molecules," which focuses on transactive response DNA binding protein with a molecular weight of 43 kDa (TDP-43). This invention relates to TDP-43 specific binding molecules, particularly anti-TDP-43 antibodies, and their use in diagnosing and treating disorders associated with misfolded TDP-43, including frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD). The invention also includes modified conformation-specific antigenic peptides derived from the TDP-43 protein.

Career Highlights

Oskar has worked with notable companies in the biotechnology sector, including Ac Immune SA and Genentech, Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Throughout his career, Oskar has collaborated with esteemed colleagues such as Andreas Muhs and Isidro Hotzel. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Oskar Adolfsson's innovative work in antibody research positions him as a key figure in the fight against neurological disorders. His patents and collaborations reflect a commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.